Aristotle University Of Thessaloniki (AUTH)
Πρώϊμοι δείκτες ενδοθηλιοπάθειας σε μετεμμηνοπαυσιακές γυναίκες που λαμβάνουν θεραπεία ορμονικής υποκατάστασης
Abstract
dc:descriptionIntroduction-Objective: Endothelial dysfunction is considered the first step for the development of atherosclerosis and cardiovascular disease. The detection of endothelial dysfunction in a preclinical stage gives the possibility of early treatment. Among other biochemical markers adhesion molecules are used at this direction. It is known that during menopause the risk for the development of cardiovascular disease is increased compared to reproduction age. The principal aim of this study was the evaluation of tibolone effect, a substance which is used as hormonal therapy in menopause for the management of vasomotor symptoms and osteoporosis on the levels of two adhesion molecules ICAM-1 and VCAM-1. It is noted that data are extremely limited. Secondary aim of this study was the evaluation of the tibolone effect on lipids. Patients and methods: In 15 healthy menopausal women (age: 50.40±0.73 years) 2.5 mg of tibolone were administered daily for 6 months. As control group 10 healthy menopausal women (age: 49.50 ± 0.67 years) were studied. The serum levels of ICAM-1, VCAM-1, total cholesterol, HDL, LDL and triglycerides were determined at the beginning, the end of the 3rd month and the end of the 6th month of tibolone administration. For statistical analysis of the results the statistical package SPSS 15.0 was used. The statistical analysis was done using t-test and General Linear Model. Results: Τhe two groups have no difference concerning age and body mass index (BMI). In tibolone group the values of ICAM-1 were 690.99±34.93, 692.98±43.42 and 631.99±51.02 at the beginning, the end of the 3rd month and the end of the 6th month of tibolone administration, while in the control group the values were 665,37±42,78, 701,54±53,18 and 657,65±62,49 respectively. There was no significant difference between the two groups concerning age and BMI. In tibolone group serum VCAM-1 values were 915,06±88,28, 920,63±84,56 and 891,46±100,35 at the beginning of the study, the end of the 3rd month, and the end of the 6th month of tibolone administration, while the levels of VCAM-1 in the control group were 890,45±108,12, 989,44±103,57 and 907,24±122,90 respectively. Finally, no significant difference was revealed on the levels of total cholesterol, HDL, LDL and triglycerides. Conclusion: Tibolone therapy has no adverse effect on the expression of adhesion molecules ICAM-1 and VCAM-1 in healthy menopausal women. Consequently, tibolone therapy in menopause could be considered as a safe choice concerning cardiovascular system.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Masouridou, Nicole
- Μασουρίδου, Νικόλ
Subjects
dc:subject × 20- Δείκτες ενδοθηλιοπάθειας
- Εμμηνόπαυση
- Ορμονική υποκατάσταση
- Κυτταρικά μόρια προσκόλλησης ICAM-1, VCAM-1
- Τιμπολόνη
- Καρδιακή νόσος
- Ενδοθηλιοπάθεια
- Αρτηριοσκλήρυνση
- Markers of endothelium disease
- Menopause
- Hormonal replacement
- Adhesion molecules
- Tibolone
- Cardiovascular disease
- Endothelial disease
- Arteriosclerosis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19461